The file room
Every story on file, newest first. Filter by bay, region or how far a plant has got.
7 of 33 stories
B1Plants
Sanofi has started building a new insulin ingredient plant at Frankfurt-Höchst, backed by 400 million euros in German aid that obliges it to make at least 1.1 tonnes a year until 2042. Full output is planned for 2032.
B3Trade
The MHRA and West Midlands Police seized more than 12,000 fake retatrutide and tirzepatide pens and packaging for 30,000 more at a Birmingham industrial unit, valued at about £2 million. It is the fourth such raid in a year.
B3Trade
A joint statement set out a 15% ceiling on US tariffs for most EU goods, and said pharmaceuticals would be held to the same ceiling.
B1Plants
The Swiss contract maker is bringing a large new production building online in phases, backed by long-term orders from big drug companies.
B4Deals
Novo Holdings completed its $16.5 billion purchase of contract maker Catalent and sold three of its plants to Novo Nordisk for about $11 billion.
B1Plants
About $6 billion goes into the harbour town where Novo already makes much of its ingredient. The plan covers several new buildings.
B1Plants
Lilly chose a town in Germany's wine country for its first big new plant in continental Europe in years, aimed at injectable medicines.
